In Biopharmaceutical industry freezing and thawing are two primary manufacturing processes. Freeze and thaw systems consist of containers for the process development, and freeze and thaw bags are also available for the same. Freeze and thaw systems are available with three principal components, cooling, and heating unit; the container for freezing, transporting, and thawing of products; a freeze and thaw system to execute the processes. An advantage of freeze and thaw systems is also in research and development where the process can be performed with the minimal amount of product.
Freeze and Thaw Systems Market: Overview
Freeze and thaw containers are available as a bag which is lined by a protective shell and can be used in laboratory freezers, walk-in-freezer, cold room or temperature controlled cabinets. The containers are designed in such a way that the box ensures the protection of the biopharmaceuticals and is easy to handle. The freeze and thaw containers are available with various manufacturers in different volume sizes. Products are deeply frozen to store them for long periods and ensure that the product composition is not hindered. After the product is frozen, they can be easily stored or transported. When the product is required, it is thawed in a temperature controlled room to ensure the product is revived.
Freeze and Thaw Systems Market: Segmentation
The market for freeze and thaw systems is segmented by products, end-users and regions:
Freeze and thaw systems market is segmented by products:
Freeze and thaw systems market is segmented by end-user industries:
Contract Research Organizations, Biotechnology Companies, Research Laboratories, Others
Freeze and Thaw Systems Market: Drivers and Restraints
Freeze and thaw systems market is driven by the large biopharmaceutical industry. The biopharmaceutical companies involved in the manufacturing of drugs require freeze and thaw systems to store and transport pharmaceutical products and services. The freeze and thaw systems have multiple applications such as short process cycles, sterile designs, easy maintenance, and time-consuming. These are various factors that end users are switching to such systems. However, small scale and medium scale companies are unable to invest owing to the associated high cost of the product which restricts the growth of the freeze and thaw systems market. Additionally, biopharmaceutical companies are also involved in the long-term storage of sensitive products and require safe storage which is sometimes not ensured by various regimes. The growth of freeze and thaw systems market is also restricted owing to the cost associated with different sizes of these systems. Multiple freeze and thaw systems are not operationally optimal for large batch size.
Freeze and Thaw Systems Market: Region-wise Outlook
Geographically, the freeze and thaw systems market are segmented into North America, Latin America, Europe, Asia-Pacific and the Middle East and Africa. North America leads the market for freeze and thaw systems market owing to the presence of massive biotechnology and pharmaceutical companies. Europe is the second leading market for freeze and thaw systems market due to increasing presence of CRO’s in the region. Germany is one of the leading countries in providing contract research services. The Asia Pacific freeze and thaw systems market is also anticipated to grow at an increasing rate owing to increasing research expenditure in emerging economies. Asia Pacific region is accounted as a fastest growing region for freeze and thaw systems as many players have invested in the development of new drugs. These factors are likely to drive the market growth of freeze and thaw systems market during the forecast period globally.
A Sample of this Report is Available Upon Request @http://www.persistencemarketresearch.com/samples/15760
Freeze and Thaw Systems Market: Key Players
The major players in freeze and thaw systems market include Zeta Holding GmbH, Sartorius Group, Farrar Scientific, Thermo Fisher Scientific, Integrated Biosystem Inc., HOF Enterprise Group, Caron, MedCision, Stewart Ingredient Systems Inc. among others. Companies have several ongoing kinds of research for the manufacturing of biopharmaceuticals which would escalate the freeze and thaw systems market. It has been found that companies have a rich development pipeline which ensures market growth during the forecast period.